Trial Profile
Open-label, Single-center, Prospective Study on the Efficacy and Safety of Repository Corticotropin Injection (H.P. ACTHAR GEL) in the Treatment of Adults With Non-infectious Retinal Vasculitis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2021
Price :
$35
*
At a glance
- Drugs Corticotropin (Primary)
- Indications Vasculitis
- Focus Therapeutic Use
- 10 Sep 2019 Planned number of patients changed from 20 to 40.
- 10 Sep 2019 Planned End Date changed from 1 Dec 2018 to 1 Aug 2020.
- 10 Sep 2019 Planned primary completion date changed from 1 Aug 2018 to 1 Feb 2020.